Boundless Bio, Inc.

Boundless Bio, Inc.verified

BOLD

Price:

$1.1

Market Cap:

$24.62M

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc...[Read more]

Industry

Biotechnology

IPO Date

2016-07-20

Stock Exchange

NASDAQ

Ticker

BOLD

The Enterprise Value as of December 2025 (TTM) for Boundless Bio, Inc. (BOLD) is 59.44M

According to Boundless Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 59.44M. This represents a change of 2.50% compared to the average of 57.99M of the last 4 quarters.

Boundless Bio, Inc. (BOLD) Historical Enterprise Value (quarterly & annually)

How has BOLD Enterprise Value performed in the past?

The mean historical Enterprise Value of Boundless Bio, Inc. over the last ten years is -27653058.85. The current 59.44M Enterprise Value has changed -21593.89% with respect to the historical average. Over the past ten years (40 quarters), BOLD's Enterprise Value was at its highest in in the March 2024 quarter at 277.50M. The Enterprise Value was at its lowest in in the March 2018 quarter at -225810559.72.

Quarterly (TTM)
Annual

Average

-27653058.85

Median

-31788559.72

Minimum

-137283559.72

Maximum

70.30M

Boundless Bio, Inc. (BOLD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Boundless Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 331.86%

Maximum Annual Enterprise Value = 70.30M

Minimum Annual Increase = -426.81%

Minimum Annual Enterprise Value = -137283559.72

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202470.30M-426.81%
2023-21510777.61272.95%
2022-5767777.61-82.99%
2021-33911777.61-75.30%
2018-137283559.72331.86%
2017-31788559.72-5.41%

Boundless Bio, Inc. (BOLD) Average Enterprise Value

How has BOLD Enterprise Value performed in the past?

The current Enterprise Value of Boundless Bio, Inc. (BOLD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

14.34M

5-year avg

-25635058.51

10-year avg

-27653058.85

Boundless Bio, Inc. (BOLD) Enterprise Value vs. Peers

How is BOLD’s Enterprise Value compared to its peers?

Boundless Bio, Inc.’s Enterprise Value is greater than Q32 Bio Inc. (6.85M), greater than NextCure, Inc. (33.89M), greater than Plus Therapeutics, Inc. (26.35M), greater than Intensity Therapeutics, Inc. (14.75M), greater than Iterum Therapeutics plc (10.14M), greater than AN2 Therapeutics, Inc. (10.96M), greater than Pluri Inc. (46.18M), greater than Rallybio Corporation (18.77M), greater than Sonnet BioTherapeutics Holdings, Inc. (8.18M), greater than TAO Synergies Inc. (8.89M),

Build a custom stock screener for Boundless Bio, Inc. (BOLD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boundless Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Boundless Bio, Inc. (BOLD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Boundless Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Boundless Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Boundless Bio, Inc. (BOLD)?

What is the 3-year average Enterprise Value for Boundless Bio, Inc. (BOLD)?

What is the 5-year average Enterprise Value for Boundless Bio, Inc. (BOLD)?

How does the current Enterprise Value for Boundless Bio, Inc. (BOLD) compare to its historical average?